Dr. Carlos Barrios discusses the use of CDK46 inhibitors in the management of breast cancer, highlighting a specific case study and the effectiveness of these inhibitors in improving patient outcomes.
00:20 - Case Overview
02:46 - Treatment and Progress
05:04 -Â Mechanism of Action
07:21 - Clinical Significance and Toxicities